Mapping AAC1, AAC2 and AACP, the genes for arylamine N-acetyltransferases, carcinogen metabolising enzymes on human chromosome 8p22, a region frequently deleted in tumours

Cytogenetics and Cell Genetics

Volumn 77, Issue 3-4, 1997, Pages 290-295

  Matas, N ^a   Thygesen, P ^a,b,c   Stacey, M ^a   Risch, A ^a   Sim, E ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARYLAMINE ACETYLTRANSFERASE; CARCINOGEN;

ARTICLE; BLADDER CANCER; CHROMOSOME 8P; GENE MAPPING; GENETIC SUSCEPTIBILITY; HUMAN; PRIORITY JOURNAL; PSEUDOGENE; RESTRICTION MAPPING; YEAST ARTIFICIAL CHROMOSOME;

ALIAS;

EID: 0030880510     PISSN: 03010171     EISSN: None     Source Type: Journal    
DOI: 10.1159/000134601     Document Type: Article

References (44)

1. Ambrosone CB, Freudenheim JL, Graham S, Marshall JR, Vena JE, Brasure JR, Michalek AM, Laughlin R, Nemoto T, Gillenwater KA, Harrington AM, Shields PG: Cigarette smoking, N-acetyltransferase 2 genetic polymorphisms, and breast cancer risk. JAMA 276:1494-1498 (1996).
2. Anand R, Riley JH, Butler R, Smith JC, Markham AF: A 3.5 genome equivalent multi access YAC library: construction, characterisation, screening and storage. Nucl Acids Res 18:1951-1956 (1990).
3. Antequera F, Bird A: Number of CpG islands and genes in human and mouse. Proc natl Acad Sci, USA 90:11995-11999 (1993).
4. Badawi AF, Hirvonen A, Bell, DA, Lang NP, Kadlubar FF: Role of aromatic amine acetyltransferases. NAT1 and NAT2, in carcinogen-DNA adduct formation in the human urinary bladder. Cancer Res 55:5230-5237 (1995).
5. Bell DA, Badawi AF, Lang NP, Ilett KF, Kadlubar FF, Hirvonen A: Polymorphism in the N-acetyltransferase 1 (NAT1) polyadenylation signal: association of NAT1*10 allele with higher N-acetylation activity in bladder and colon tissue. Cancer Res 55:5226-52299 (1995a).
6. Bell DA, Stephens EA, Castranio T, Umbach DM, Watson M, Deakin M, Elder J, Hendrickse C, Duncan H, Strange RC: Polyadenylation polymorphism in the acetyltransferase 1 gene (NAT1) increases risk of colorectal cancer. Cancer Res 55:3537-3542 (1995b).
7. Blum M, Grant DM, McBride W, Heim M, Meyer UA: Human arylamine N-acetyltransferase genes: isolation, chromosomal localization, and functional expression. DNA Cell Biol 9:193-203 (1990).
8. Bookstein R: Tumor suppressor genes in prostatic oncogenesis. J Cell Biochem Suppl 19:217-223 (1994).
9. Bookstein R, Levy A, MacGrogan D, Lewis TB, Weissenbach J, O'Connell P, Leach RJ: Yeast artificial chromosome and radiation hybrid map of loci in chromosome band 8p22, a common region of allelic loss in multiple human cancers. Genomics 24:317-323 (1994).
10. Boycott KM, Halley GR, Schlessinger D, Bech Hansen NT: A 2-megabase physical contig incorporating 43 DNA markers on the human X chromosome at p11.23→p11.22 from ZNF21 to DXS255. Genomics 33:488-497 (1996).
11. Cartwright RA, Glashan RW, Rogers HJ, Ahmad RA, Barham Hall D, Higgins E: Kahn MA: Role of N-acetyltransferase phenotypes in bladder carcinogenesis: a pharmacogenetic epidemiological approach to bladder cancer. Lancet 2:842-845 (1982).
12. Cascorbi I, Brockmoller J, Bauer S, Reum T, Roots I: NAT2*12A (803A>G) codes for rapid arylamine N-acetylation in humans. Pharmacogenetics 16:257-259 (1996).
13. Case RA, Hosker ME, McDonald DB, Pearson JT: Tumours of the urinary bladder in workmen engaged in the manufacture and use of certain dyestuff intermediates in the British chemical industry. Part I. The role of aniline, benzidine, alpha-naphthylamine, and beta-naphthylamine. Brit J Ind Med 50:389-411 (1954).
14. Cribb AE, Grant DM, Miller MA, Spielberg SP: Expression of monomorphic arylamine N-acetyltransferase (NAT1) in human leukocytes. J Pharmacol Exp Ther 259:1241-1246 (1991).
15. Delomenie C, Sica L, Grant DM, Krishnamorthy R, Dumpret SM: Genotyping of the polymorphic N-acetyltransferase (NAT2*) gene locus in two native African populations. Pharmacogenetics 6:177-185 (1996).
16. Emi M, Fujiwara Y, Nakajima T, Tsuchiya E, Tsuda H, Hirohashi S, Maeda Y, Tsuruta K, Miyaki M, Nakamura Y: Frequent loss of heterozygosity for loci on chromosome 8p in hepatocellular carcinoma, colorectal cancer, and lung cancer. Cancer Res 52:5368-5372 (1992).
17. Farrington SM, Cunningham C, Boyle SM, Wyllie AH, Dunlop MG: Detailed physical and deletion mapping of 8p with isolation of YAC clones from tumour suppressor loci involved in colorectal cancer. Oncogene 12:1803-1808 (1996).
18. Fleming CM, Persad R, Kaisary A, Smith P, Adedoyin A, Porter J, Wilkinson GR, Branch RA: Low activity of dapsone N-hydroxylation as a susceptibility risk factor in aggressive bladder cancer. Pharmacogenetics 4:199-207 (1994).
19. Franke S, Klawitz I, Schnakenberg E, Rommel B: Isolation and mapping of a cosmid clone containing the human NAT2 gene. Biochem biophys Res Commun 199:52-55 (1994).
20. Fujiwara Y, Emi M, Ohata H, Kato Y, Nakajima T, Mori T, Nakamura Y: Evidence for the presence of two tumor suppressor genes on chromosome 8p for colorectal carcinoma. Cancer Res 53:1172-1174 (1993).
21. Glowinski IB, Weber WW: Localization of murine N-acetyltransferase gene. Mouse News Letter 64:71 (1981).
22. Grant DM: Molecular genetics of the N-acetyltransferases. Pharmacogenetics 3:45-50 (1993).
23. Hickman D, Risch A, Camilleri JP, Sim E: Genotyping human polymorphic arylamine N-acetyltransferase: identification of new slow aliotypic variants. Pharmacogenetics 2:217-226 (1992).
24. Hickman D, Risch A, Buckle V, Spurr NK, Jeremiah SJ, McCarthy A, Sim E: Chromosomal localization of human genes for arylamine N-acetyltransferase. Biochem J 297:441-445 (1994).
25. Kelemen PR, Yaremko ML, Kim AH, Montag A, Michelassi F, Westbrook CA: Loss of heterozygosity in 8p is associated with microinvasion in colorectal carcinoma. Genes Chrom Cancer 11:195-198 (1994).
26. Kelly SL, Sim E: Arylamine N-acetyltransferase in Balb/c mice: identification of a novel mouse isoenzyme by cloning and expression in vitro. Biochem J 302:347-353 (1994).
27. Knowles MA, Shaw ME, Proctor AJ: Deletion mapping of chromosome 8 in cancers of the urinary bladder using restriction fragment length polymorphisms and microsatellite polymorphisms. Oncogene 8:1357-1364 (1993).
28. Lin HJ, Han CY, Lin BK, Hardy S: Ethnic distribution of slow acetylator mutations in the polymorphic N-acetyltransferase (NAT2) gene. Pharmacogenetics 4:125-134 (1994).
29. Martell KJ, Vatsis KP, Weber WW: Molecular genetic basis of rapid and slow acetylation in mice. Mol Pharmacol 40:218-227 (1991).
30. Matas N, Stacey M, Thygesen P, Risch A, Leach R, Lewis T, Wood S, Sim E: Physical mapping of the genes for human arylamine N-acetyltransferases, bladder carcinogen metabolising enzymes, within 8p22 - a region frequently deleted in invasive bladder cancer. (Abstract) Cytogenet Cell Genet 75:71-84 (1996).
31. Mattano SS, Erickson RP, Nesbitt MN, Weber WW: Linkage of Nat and Es-1 in the mouse and development of strains congenic for N-acetyltransferase. J Hered 79:430-433 (1988).
32. Risch A, Wallace DMA, Bathers S, Sim E: Slow N-acetylation genotype is a susceptibility factor in occupational and smoking related bladder cancer. Hum molec Genet 4:231-236 (1995).
33. Risch A, Smelt V, Lane D, Stanley L, van der Slot W, Ward A, Sim E: Arylamine N-acetyltransferase in erythrocytes of cystic fibrosis patients. Pharm Toxicol 78:235-240 (1996).
34. Sambrook J, Fritsch EF, Maniatis T: Molecular cloning: a laboratory manual. 2nd ed (Cold Spring Harbour Laboratory Press, Cold Spring Harbour 1989).
35. Spurr NK, Blanton S, Bookstein R, Clarke R, Cottingham R, Daiger S, Drayna D, Faber P, Horrigan S, Kas K, Kirchgessner C, Kumar S, Leach RJ, Luedecke H-J, Nakamura Y, Pebusque M-J, Rants S, Sim E, Sullivan LS, Tackle L, Vance J, Wagner D, Wells C, Westbrook C, Yaremko L, Zaletayev D, Zuffardi O, Wood S: Report of the second international workshop on human chromosome 8 mapping 1994. Cytogenet Cell Genet 68:147-164 (1995).
36. Stacey M, Thygesen P, Stanley L, Matas N, Risch A, Sim E: Arylamine N-acetyltransferase as a potential biomarker in bladder cancer: fluorescent in situ hybridization and immunohistochemistry studies, Biomarkers 1:55-61 (1996).
37. Steinbrueck T, Read C, Daiger SP, Sadler LA, Weber JL, Donis-Keller H: A comprehensive genetic linkage map of the human genome [Chromosome 8]. Science :258:67-86 (1992).
38. Taylor JA, Umbach D, Stephens E, Paulson D, Robertson C, Mohler JL, Bell DA: Role of N-acetylation polymorphism at NAT1 and NAT2 in smoking-associated bladder cancer. Proc Am Cancer Assoc 36:282 (1995).
39. Vatsis KP, Weber WW: Structural heterogeneity of Caucasian N-acetyltransferase at the NAT1 gene locus. Arch Biochem Biophys 301:71-76 (1993).
40. Vatsis KP, Weber WW, Bell DA, Dupret JM, Evans DA, Grant DM, Hein DW, Lin HJ, Meyer UA, Relling MV, Sim E, Suzuki T, Yamazoe Y: Nomenclature for N-acetyltransferases. Pharmacogenetics 5:1-17 (1995).
41. Ward A, Hickman D, Gordon JW, Sim E: Arylamine N-acetyltransferase in human red blood cells. Biochem Pharmacol 44:1099-104 (1992).
42. Weber WW, Vatsis KP: Individual variability in p-aminobenzoic acid N-acetylation by human N-acetyltransferase (NAT1) of peripheral blood. Pharmacogenetics 3:209-212 (1993).
43. Weissenbach J, Gyapay G, Dib C, Vignal A, Morissette J, Millasseau P, Vaysseix G, Lathrop M: A second-generation linkage map of the human genome. Nature 359:794-801 (1992).
44. Wood S, Ben Othmane K, Bergerheim US, Blanton SH, Bookstein R, Clarke RA, Daiger SP, Donis Keller H, Drayna D, Kumar S et al: Report of the first international workshop on human chromosome 8 mapping. Cytogenet Cell Genet 64:133-146 (1993).